OP 2104
Alternative Names: OP-2104Latest Information Update: 10 Feb 2023
At a glance
- Originator OrchestratePharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Sinusitis
Most Recent Events
- 26 Jul 2022 Early research in Sinusitis in Switzerland (unspecified route), prior to July 2022 (Orchestrate Pharma pipeline, July 2022)